Nxera Pharma Soars 16.4%, Hits Intraday High of JPY 1,022.00

Nxera Pharma Co., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge today, gaining 16.4% as of April 1, 2026. The stock reached an intraday high of JPY 1,022.00, marking a notable performance against the backdrop of the Japan Nikkei 225, which rose by 5.24% on the same day. Over the past week, Nxera Pharma has shown a robust increase of 15.47%, contrasting sharply with the Nikkei's slight decline of 0.02%. In the longer term, the stock has demonstrated a 22.73% year-to-date performance, significantly outperforming the Nikkei's 6.75% gain. However, the company has faced challenges, with a one-year performance of 12.65% that lags behind the Nikkei's impressive 50.85% return. Despite today's positive movement, Nxera Pharma has struggled with long-term fundamentals, including a negative EBIT and a declining trend in net sales. The company's market cap stands at JPY 73,212 million, and it continues to navigate a complex financial landscape.